Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Max Healthcare Institute Ltd ( (IN:MAXHEALTH) ) has issued an announcement.
Max Healthcare Institute Ltd has released its financial results for the quarter and half-year ended September 30, 2025, showing a significant increase in revenue and profit compared to the previous year. The company reported consolidated revenue from operations of ₹213,547 lakhs for the quarter, with a profit after tax of ₹49,130 lakhs. A notable development is the merger of its subsidiaries, Crosslay Remedies Limited and Jaypee Healthcare Limited, approved by the NCLT, which resulted in tax benefits. Additionally, the company divested two hospitals in line with its strategic focus on larger cities, and a final dividend was approved and paid to shareholders.
More about Max Healthcare Institute Ltd
Max Healthcare Institute Ltd is a prominent player in the healthcare industry, focusing on providing super specialty healthcare services. The company operates a network of hospitals and healthcare facilities, primarily targeting major urban centers to deliver advanced medical care.
Average Trading Volume: 74,794
Technical Sentiment Signal: Buy
Current Market Cap: 1070.8B INR
For a thorough assessment of MAXHEALTH stock, go to TipRanks’ Stock Analysis page.